BIOMAT Database Logo BIOMAT Database Logo

[Prevalence of obesity in post-menopausal women treated with estrogens]. 1982

M Verdy, and C Morin, and E Bolté

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

M Verdy, and C Morin, and E Bolté
[Decrease of breast and endometrial neoplasms in post-menopausal women treated with estrogens].
October 1977, Ginekologia polska,
M Verdy, and C Morin, and E Bolté
[Estrogens and estrogen therapy in post-menopausal women].
July 1968, Rivista di ostetricia e ginecologia,
M Verdy, and C Morin, and E Bolté
Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times.
April 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M Verdy, and C Morin, and E Bolté
Lipoprotein(a) serum levels in post-menopausal women treated with oral estrogens administered at different times.
August 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M Verdy, and C Morin, and E Bolté
Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women.
January 2015, Hormone molecular biology and clinical investigation,
M Verdy, and C Morin, and E Bolté
Obesity in post menopausal women with a family history of breast cancer: prevalence and risk awareness.
January 2009, International seminars in surgical oncology : ISSO,
M Verdy, and C Morin, and E Bolté
[Prolactin and estrogens in osteoporosis in post-menopausal women (author's transl)].
May 1982, Medicina clinica,
M Verdy, and C Morin, and E Bolté
Post-menopausal osteoporosis and estrogens. Who should be treated and why.
February 1984, Postgraduate medicine,
M Verdy, and C Morin, and E Bolté
[Estrogens and infarction in menopausal women].
January 1995, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
M Verdy, and C Morin, and E Bolté
Urine estrogens and breast cancer risk factors among post-menopausal women.
December 1987, International journal of cancer,
Copied contents to your clipboard!